[1]谢红英,罗晓丽,卢慧.黄芪注射液对病毒性心肌炎患者外周血NLRP3炎性小体表达的影响[J].西部中医药,2021,34(07):94-97.[doi:10.12174/j.issn.2096-9600.2021.07.24]
　XIE Hongying,LUO Xiaoli,LU Hui.Influence of Huangqi Injection on the Expressions of NLRP3 Inflammasome in Peripheral Blood of Patients with Viral Myocarditis[J].Western Journal of Traditional Chinese Medicine,2021,34(07):94-97.[doi:10.12174/j.issn.2096-9600.2021.07.24]
点击复制

黄芪注射液对病毒性心肌炎患者外周血NLRP3炎性小体表达的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年07期
页码:
94-97
栏目:
出版日期:
2021-07-15

文章信息/Info

Title:
Influence of Huangqi Injection on the Expressions of NLRP3 Inflammasome in Peripheral Blood of Patients with Viral Myocarditis
作者:
谢红英1, 罗晓丽1, 卢慧2
1.陆军军医大学（第三军医大学）大坪医院野战外科研究所心血管内科，重庆 400042
2.中交二航局第二工程有限公司卫生所
Author(s):
XIE Hongying1, LUO Xiaoli1, LU Hui2
1.Department of Cardiology, Daping Hospital & Institute of Surgery Research, Army Medical University (The Third Military Medical University), Chongqing 400042, China
2.Health Center, China Communications 2nd Navigational Bureau 2nd Engineering Co., Ltd.
关键词:
病毒性心肌炎; 核苷酸结合寡聚化结构域样受体蛋白3; 半胱氨酸蛋白酶1; 黄芪注射液
Keywords:
viral myocarditis; NLRP3; Caspase-1; injection
分类号:
R272
DOI:
10.12174/j.issn.2096-9600.2021.07.24
摘要:
目的探讨黄芪注射液对病毒性心肌炎患者外周血核苷酸结合寡聚化结构域样受体蛋白3（nucleotide-binding oligomerization domain-like receptors family pyrin domain containing 3,NLRP3）炎性小体表达的影响。 方法将病毒性心肌炎患者160例根据随机数字表法分为黄芪注射液治疗组（观察组）和常规治疗组（对照组）各80例。观察两组临床疗效及不良反应发生情况，比较治疗前后两组患者外周血单个核细胞（peripheral blood mononuclear cells,PBMCs）中NLRP3、半胱氨酸蛋白酶1（Caspase-1）mRNA表达水平及白细胞介素1β(interleukin-1β，IL-1β)、白细胞介素1(interleukin-1，IL-1)、心肌肌钙蛋白I（cardiac troponin I,cTnI）和肌酸激酶同工酶MB（creatine kinase isoenzymes-MB,CKMB）水平。 结果与对照组比较，观察组治疗后外周血NLRP3、Caspase-1 mRNA及IL-1β和IL-18水平降低（P＜0.05）；治疗后两组患者血清CKMB、cTnI水平均较治疗前降低，观察组降低更明显（P＜0.05）；观察组总有效率高于对照组（P＜0.05）；不良反应两组比较差异无统计学意义（P＞0.05）。 结论黄芪注射液可降低病毒性心肌炎患者外周血NLRP3炎性小体表达水平，从而提高临床疗效。
Abstract:
ObjectiveTo observe the effect of Huangqi injection on the expression of NLRP3 inflamma-some in peripheral blood of patients with viral myocarditis. MethodsAll 160 patients were divided into the treatment group of Huangqi injection (the observation group) and conventional treatment group (the control group) according to randome number table method, 80 cases in each group. To observe clinical effects and the incidences of adverse reaction in two groups, to compare the expressions of NLRP3 in PBMCs, Caspase-1 mRNA, the levels of IL-1β, IL-1, CKMB and cTn1 in peripheral blood of the patients between both groups before and after treating. ResultsCompared with the control group, the levels of NLRP3, Caspase-1 mRNA, IL-1β and IL-18 in peripheral blood lowered in the observation group (P<0.05); the levels of CKMB and cTn1 reduced in both groups after treating than these before treating, and the decrease of the observation group was more notable (P<0.05); the observation group was higher than the control group in total effective rate (P<0.05); the difference had no statistical meaning between both groups in adverse reaction (P>0.05). ConclusionHuangqi injection could lower the expressions of NLRP3 in peripheral blood of the patients with viral myocarditis, therefore to raise clinical effects.

相似文献/References:

[1]冯珊珊.病毒性心肌炎合并Ⅲ度房室传导阻滞护理预防措施及效果[J].西部中医药,2015,28(08):164.
[2]陈士利.舒血宁治疗心肌炎60例临床观察[J].西部中医药,2014,27(04):92.
　CHEN Shili.Curative Observation on ShuXueNing Injection for 60 Cases of Viralmyocarditis[J].Western Journal of Traditional Chinese Medicine,2014,27(07):92.
[3]王亚玲,王昌明,李晓.复方斑蝥胶囊辅助治疗对胃癌患者临床疗效及外周血NLRP3炎性小体表达的影响[J].西部中医药,2022,35(07):72.[doi:10.12174/j.issn.2096-9600.2022.07.19]
　WANG Yaling,WANG Changming,LI Xiao.Clinical Effects of Compound Banmao Capsules Adjuvant Therapy in Treating Gastric Cancer and Its Influence on the Expressions of NLRP3 Inflammasome in Peripheral Blood[J].Western Journal of Traditional Chinese Medicine,2022,35(07):72.[doi:10.12174/j.issn.2096-9600.2022.07.19]
[4]杨闻君,罗秋林,张强.黄芪注射液对病毒性心肌炎患者外周血Th17及Treg细胞亚群的影响[J].西部中医药,2022,35(09):91.[doi:10.12174/j.issn.2096-9600.2022.09.17]
　YANG Wenjun,LUO Qiulin,ZHANG Qiang.Effects of Huangqi Injection on Th17 and Treg Cell Subsets in Peripheral Blood of Patients with Viral Myocarditis[J].Western Journal of Traditional Chinese Medicine,2022,35(07):91.[doi:10.12174/j.issn.2096-9600.2022.09.17]
[5]陈晋玉,雷瑗琳,王南丁.中医药干预NLRP3炎症小体治疗动脉粥样硬化的研究进展[J].西部中医药,2024,37(04):112.[doi:10.12174/j.issn.2096-9600.2024.04.22]
　CHEN Jinyu,LEI Yuanlin,WANG Nanding.Research Progress of TCM Intervention of NLRP3 Inflammasome in the Treatment of Atherosclerosis[J].Western Journal of Traditional Chinese Medicine,2024,37(07):112.[doi:10.12174/j.issn.2096-9600.2024.04.22]
[6]张平安,高娜,姚涛,等.基于网络药理学与GEO数据库探讨心瘅方治疗病毒性心肌炎的机制[J].西部中医药,2024,37(05):101.[doi:10.12174/j.issn.2096-9600.2024.05.19]
　ZHANG Ping'an,GAO Na,YAO Tao,et al.Exploration into the Mechanism of Xindan Formula (Heart-heat Formula) in the Treatment of Viral Myocarditis based on Network Pharmacology and GEO Database[J].Western Journal of Traditional Chinese Medicine,2024,37(07):101.[doi:10.12174/j.issn.2096-9600.2024.05.19]

备注/Memo

备注/Memo:
谢红英（1968—），女，副主任医师。研究方向：病毒性心肌炎的临床诊治。国家自然科学基金（81300197）。
更新日期/Last Update: 2021-07-15